AFP and cancer: Model analysis pointed out some differences between the two biomarkers: the mean life-time of PIVKA-II (2.0–5.0 days) was shorter than that of AFP (9.1–10.0 days in all cases but one), the latter being closer to that of cancer cells (9.1 days).